NCT07542652 Association Between Microplastic Exposure and the Pathological Progression of Gastric Carcinogenesis
| NCT ID | NCT07542652 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yongquan Shi |
| Condition | Gastric Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 450 participants |
| Start Date | 2026-03-31 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 450 participants in total. It began in 2026-03-31 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this clinical trial is to explore the correlation between the level of microplastic exposure and the risk of gastric mucosal carcinogenesis, and to evaluate the strength of its effect as an independent risk factor. The main questions it aims to answer include: Does the level of microplastic exposure increase the risk of gastric mucosal carcinogenesis? Can the correlation between the level of microplastic exposure and gastric mucosal carcinogenesis, as well as the sources of high - risk microplastic exposure, be explored through a questionnaire on external microplastic exposure? Researchers will complete a design structured questionnaire and ask participants to fill it out carefully and truthfully to determine whether the level of microplastic exposure increases the risk of gastric mucosal carcinogenesis.
Eligibility Criteria
Inclusion Criteria: * Aged between 18 and 75 years old, gender is not restricted * Having a clear diagnosis result within the recent three months and being diagnosed with chronic non - atrophic gastritis, precancerous lesions of gastric cancer, or gastric cancer for the first time * Have clear Helicobacter pylori (Hp) test results * Be in normal mental state and able to independently complete the questionnaire survey Exclusion Criteria: * Patients with a history of malignant tumors in other parts * Patients who have previously undergone upper gastrointestinal surgery, chemotherapy, or radiotherapy * Patients with severe diseases of major organs such as the heart, lungs liver, and kidneys * Patients who are currently receiving psychological intervention or taking psychiatric drugs * Pregnant or lactating women * Patients with severe missing clinical data or questionnaire information * Refusing to sign the informed consent form
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07542652 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Gastric Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07542652 currently recruiting?
Yes, NCT07542652 is actively recruiting participants. Contact the research team at shiyquan@fmmu.edu.cn for enrollment information.
Where is the NCT07542652 trial being conducted?
This trial is being conducted at Xi'an, China.
Who is sponsoring the NCT07542652 clinical trial?
NCT07542652 is sponsored by Yongquan Shi. The trial plans to enroll 450 participants.